Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PASS (Promote Access to Stop Suicide): A Randomized Controlled Trial Comparing Enhanced Treatment as Usual, Crisis Center Follow up and Wraparound Services for Youth at Risk for Suicide

NCT03016572 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03016572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03016572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PASS (Promote Access to Stop Suicide): A Randomized Controlled Trial Comparing Enhanced Treatment as Usual, Crisis Center Follow up and Wraparound Services for Youth at Risk for Suicide
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
May 4, 2017
Completion date
August 31, 2021
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depressive disorder, major, suicidal ideation, suicidal impulses, suicide